MedPath

Boryung Pharmaceutical Co., Ltd.

🇰🇷South Korea
Ownership
-
Employees
-
Market Cap
-
Website

The Effects of Cilnidipine on Metabolic Syndrome Improvement

Phase 4
Completed
Conditions
Metabolic Syndrome X
Hypertension
Interventions
First Posted Date
2006-05-15
Last Posted Date
2008-08-27
Lead Sponsor
Boryung Pharmaceutical Co., Ltd
Target Recruit Count
186
Registration Number
NCT00325936
Locations
🇰🇷

Cheil general hospital, Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath